ENST00000784515.1:n.209+1867_209+1868insACACACACACACACAC

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

The ENST00000784515.1(ENSG00000302122):​n.209+1867_209+1868insACACACACACACACAC variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.085 ( 748 hom., cov: 0)

Consequence

ENSG00000302122
ENST00000784515.1 intron

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.32

Publications

9 publications found
Variant links:
Genes affected
GRIN2A (HGNC:4585): (glutamate ionotropic receptor NMDA type subunit 2A) This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]
GRIN2A Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Landau-Kleffner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • continuous spikes and waves during sleep
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • rolandic epilepsy-speech dyspraxia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • self-limited epilepsy with centrotemporal spikes
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENSG00000302122ENST00000784515.1 linkn.209+1867_209+1868insACACACACACACACAC intron_variant Intron 1 of 2
ENSG00000302122ENST00000784516.1 linkn.209+1867_209+1868insACACACACACACACAC intron_variant Intron 1 of 1
ENSG00000302122ENST00000784517.1 linkn.208+1867_208+1868insACACACACACACACAC intron_variant Intron 1 of 2
GRIN2AENST00000675398.2 linkc.-1124_-1123insGTGTGTGTGTGTGTGT upstream_gene_variant ENSP00000502752.1 A0A6Q8PHM7

Frequencies

GnomAD3 genomes
AF:
0.0845
AC:
10581
AN:
125212
Hom.:
749
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0490
Gnomad AMI
AF:
0.0813
Gnomad AMR
AF:
0.0709
Gnomad ASJ
AF:
0.0832
Gnomad EAS
AF:
0.0481
Gnomad SAS
AF:
0.0824
Gnomad FIN
AF:
0.121
Gnomad MID
AF:
0.0698
Gnomad NFE
AF:
0.106
Gnomad OTH
AF:
0.0612
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0845
AC:
10588
AN:
125278
Hom.:
748
Cov.:
0
AF XY:
0.0809
AC XY:
4797
AN XY:
59318
show subpopulations
African (AFR)
AF:
0.0491
AC:
1591
AN:
32430
American (AMR)
AF:
0.0706
AC:
901
AN:
12760
Ashkenazi Jewish (ASJ)
AF:
0.0832
AC:
265
AN:
3186
East Asian (EAS)
AF:
0.0483
AC:
195
AN:
4040
South Asian (SAS)
AF:
0.0828
AC:
272
AN:
3286
European-Finnish (FIN)
AF:
0.121
AC:
838
AN:
6942
Middle Eastern (MID)
AF:
0.0672
AC:
16
AN:
238
European-Non Finnish (NFE)
AF:
0.106
AC:
6339
AN:
59908
Other (OTH)
AF:
0.0628
AC:
106
AN:
1688
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
402
804
1206
1608
2010
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0854
Hom.:
154

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3219790; hg19: chr16-10277424; API